Is pretreatment Epstein-Barr virus DNA still associated with 6-year survival outcomes in locoregionally advanced nasopharyngeal carcinoma?

J Cancer · 2017 · PMC5436249 · PMID 28529609

Europe PMC DOI

hedged sentence

0.0710

closest p · 1.4× alpha

0.0710

boldest claim

The sentences

did not reach statistical significanceP = 0.071so close (0.05 < p ≤ 0.1)

Compared with pre-DNA < 1500 copies/ml, patients with pre-DNA ≥ 1500 copies/ml were more likely to present with stage IVA-B, but the correlation did not reach statistical significance (P = 0.071).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.